Vanda Pharmaceuticals (VNDA) EBT Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -148.28% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -313.33% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 71.54% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -79.57% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.15% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 9,460.35% |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -29.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.59% |
| Dec 31, 2025 | -484.92% |
| Sep 30, 2025 | -354.68% |
| Jun 30, 2025 | -532.47% |
| Mar 31, 2025 | -701.20% |
| Dec 31, 2024 | -291.15% |
| Sep 30, 2024 | -5,103.33% |
| Jun 30, 2024 | -312.81% |
| Mar 31, 2024 | -184.37% |
| Dec 31, 2023 | -117.28% |
| Sep 30, 2023 | -102.20% |
| Jun 30, 2023 | -31.61% |
| Mar 31, 2023 | 173.08% |
| Dec 31, 2022 | 11.65% |
| Sep 30, 2022 | -49.07% |
| Jun 30, 2022 | -69.93% |
| Mar 31, 2022 | -172.54% |
| Dec 31, 2021 | -21.18% |
| Sep 30, 2021 | 27.63% |
| Jun 30, 2021 | 13.66% |
| Mar 31, 2021 | 740.29% |
| Dec 31, 2020 | 88.02% |
| Sep 30, 2020 | -31.57% |
| Jun 30, 2020 | -3.94% |
| Mar 31, 2020 | 306.15% |
| Dec 31, 2019 | -43.69% |
| Sep 30, 2019 | 69.02% |
| Jun 30, 2019 | 145.56% |
| Mar 31, 2019 | -119.65% |
| Dec 31, 2018 | 689.26% |
| Sep 30, 2018 | 260.44% |
| Jun 30, 2018 | 407.86% |
| Mar 31, 2018 | 140.18% |
| Dec 31, 2017 | -250.20% |
| Sep 30, 2017 | -952.79% |
| Jun 30, 2017 | 66.93% |
| Mar 31, 2017 | 38.29% |
| Dec 31, 2016 | 96.64% |
| Sep 30, 2016 | 95.49% |
| Jun 30, 2016 | 15.39% |
| Mar 31, 2016 | -20.06% |
| Dec 31, 2015 | -121.37% |
| Sep 30, 2015 | -558.91% |
| Jun 30, 2015 | 74.70% |
| Mar 31, 2015 | 61.21% |
| Dec 31, 2014 | 1,014.25% |
| Sep 30, 2014 | 73.09% |
| Jun 30, 2014 | -537.75% |
| Mar 31, 2014 | -487.14% |
| Dec 31, 2013 | -137.47% |
| Sep 30, 2013 | -1.01% |
| Jun 30, 2013 | 57.75% |
| Mar 31, 2013 | 43.24% |
| Dec 31, 2012 | 450.18% |
| Sep 30, 2012 | -67.12% |
| Jun 30, 2012 | -475.22% |
| Mar 31, 2012 | -5,707.04% |
| Dec 31, 2011 | -722.62% |
| Sep 30, 2011 | -454.51% |
| Jun 30, 2011 | -211.99% |